Conmed (CNMD) | Stock Overview & Key Data
Conmed Performance Comparison
Stock Range
Today's Range
Low: $49.59
High: $50.99
on July 29, 2025
52 Week Range
Low: $46.00
High: $78.19
on April 21, 2025
on September 13, 2024
All-Time High: $159.11 on November 1, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.6B
EPS
3.81
P/E Ratio (TTM)
13.40
Forward P/E
10.55
P/B Ratio
1.62
PEG Ratio
10.55
Div. Yield
1.15%
ROE
12.96%
Beta
1.207
Debt to Equity
91.26
Financial Highlights
Profitability
Gross Margin
55.33%
Operating Margin
7.27%
Profit Margin
9.02%
Returns and Earnings
Return on Assets (TTM)
4.14%
Return on Equity (TTM)
12.96%
EBITDA
$253.3M
Net Income (TTM)
$118.8M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$42.59
Quarterly Revenue Growth (YoY)
2.90%
Quarterly Earnings Growth (YoY)
-69.40%
Dividend Information
Last 12-Month Dividend
$0.60
Current Dividend Yield
1.15%
3-Year Average Dividend Yield
0.24%
3-Year Average Annual Dividend
$0.73
3-Year Total Dividends
$2.20
Ex-Dividend Date
March 14, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Conmed CNMD | 1.58B Small-cap | 4.71% | -3.44% | -1.72% | -28.56% | -25.33% | -26.77% | -48.16% | -40.81% |
| Abbott Laboratories ABT | 219.83B Mega-cap | 1.81% | -5.88% | -1.91% | 0.12% | 12.84% | 15.00% | 17.17% | 26.45% |
| Boston Scientific BSX | 157.52B Large-cap | 3.21% | -0.88% | 3.63% | 3.66% | 19.12% | 42.91% | 160.06% | 173.21% |
| UFP Technologies UFPT | 1.86B Small-cap | 2.84% | -2.66% | 12.32% | -13.40% | -3.48% | -24.85% | 166.60% | 431.34% |
| QuidelOrtho QDEL | 1.85B Small-cap | -0.39% | -11.73% | -10.99% | -41.54% | -43.52% | -39.44% | -72.41% | -90.67% |
| Alphatec Holdings ATEC | 1.64B Small-cap | 1.30% | -1.98% | -2.94% | -9.78% | 20.09% | 72.70% | 33.01% | 60.95% |
Ownership & Short Interest
Insider Ownership
0.58%
Institutional Ownership
116.89%
Shares Short
2M
Short Ratio
4.86
Short % of Shares Outstanding
9.31%
Average 10-Day Volume
467K
Average 90-Day Volume
445K
Conmed Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Conmed would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CNMD's 52-week high and low?
- In the last 52 weeks, Conmed reached a high of $78.19 (on September 13, 2024) and a low of $46.00 (on April 21, 2025).
- What is the market cap and P/E ratio for CNMD?
- Curious about Conmed's size and valuation? Its market capitalization stands at 1.58B. When it comes to valuation, the P/E ratio (trailing twelve months) is 13.40, and the forward P/E (looking ahead) is 10.55.
- Does CNMD pay dividends? If so, what's the yield?
- Yes, Conmed is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.15%, and the company has paid an average of $0.73 per share annually over the past 3 years.
- Who are Conmed's main competitors or similar companies to consider before investing?
When looking at Conmed, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT219.83B Healthcare Medical Devices 15.00% 17.17% Boston Scientific
BSX157.52B Healthcare Medical Devices 42.91% 160.06% UFP Technologies
UFPT1.86B Healthcare Medical Devices -24.85% 166.60% QuidelOrtho
QDEL1.85B Healthcare Medical Devices -39.44% -72.41% Alphatec Holdings
ATEC1.64B Healthcare Medical Devices 72.70% 33.01% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Conmed Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Conmed's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 12.96%, the Debt to Equity ratio from the most recent quarter is 91.26, and its Gross Profit Margin stands at 55.33%.
- What is the recent revenue and earnings growth for CNMD?
- Looking at Conmed's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 2.90%, and quarterly earnings saw a YoY growth of -69.40%.
- How much of CNMD stock is held by insiders and institutions?
- Wondering who owns Conmed stock? Company insiders (like executives and directors) hold about 0.58% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 116.89%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.